Fennec Pharmaceuticals Inc. · NASDAQ:FENC

Hackman Jeffrey S. received 1,159 Fennec Pharmaceuticals Inc. shares as an award (Form 4)

Traded Aug 31, 2026 · Filed Aug 31, 2026

On Aug 31, 2026, Hackman Jeffrey S. (Director, Chief Executive Officer) received 1,159 Fennec Pharmaceuticals Inc. shares as an award, leaving 66,302 shares. Filed Aug 31, 2026 (Form 4).

Awarded
1,159 shares
Holding after
66,302 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 31, 2026Common SharesAward1,15966,302Direct

Source

View original at SEC

Related